Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Absolute Protein Quantification by Mass Spectrometry: Not as Simple as Advertised.

Shuford CM, Walters JJ, Holland PM, Sreenivasan U, Askari N, Ray K, Grant RP.

Anal Chem. 2017 Jul 18;89(14):7406-7415. doi: 10.1021/acs.analchem.7b00858. Epub 2017 Jul 3.

PMID:
28605192
2.

Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity.

Graves JD, Kordich JJ, Huang TH, Piasecki J, Bush TL, Sullivan T, Foltz IN, Chang W, Douangpanya H, Dang T, O'Neill JW, Mallari R, Zhao X, Branstetter DG, Rossi JM, Long AM, Huang X, Holland PM.

Cancer Cell. 2014 Aug 11;26(2):177-89. doi: 10.1016/j.ccr.2014.04.028. Epub 2014 Jul 17.

3.

Asymmetric anterior uveitis as a delayed complication of treatment with systemic high-dose cytosine-arabinoside: a case report and literature review.

Grewal DS, Holland PM, Frankfurt O, Pyatetsky D.

Ocul Immunol Inflamm. 2014 Aug;22(4):322-5. doi: 10.3109/09273948.2013.801990. Epub 2014 May 15. Review. No abstract available.

PMID:
24832917
4.

Death receptor agonist therapies for cancer, which is the right TRAIL?

Holland PM.

Cytokine Growth Factor Rev. 2014 Apr;25(2):185-93. doi: 10.1016/j.cytogfr.2013.12.009. Epub 2013 Dec 24. Review.

PMID:
24418173
5.

The effect of seat shape on the risk of pressure ulcers using discomfort and interface pressure measurements.

Tasker LH, Shapcott NG, Watkins AJ, Holland PM.

Prosthet Orthot Int. 2014 Feb;38(1):46-53. doi: 10.1177/0309364613486918. Epub 2013 May 17.

PMID:
23685919
6.

Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours.

Pan Y, Xu R, Peach M, Huang CP, Branstetter D, Novotny W, Herbst RS, Eckhardt SG, Holland PM.

Br J Cancer. 2011 Dec 6;105(12):1830-8. doi: 10.1038/bjc.2011.456. Epub 2011 Oct 27.

7.

The use and validation of a laser scanner for computer aided design and manufacturing of wheelchair seating.

Tasker LH, Shapcott NG, Holland PM.

J Med Eng Technol. 2011 Aug-Oct;35(6-7):377-85. doi: 10.3109/03091902.2011.601783. Epub 2011 Sep 16.

PMID:
21919817
8.

Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL.

Holland PM.

Cancer Lett. 2013 May 28;332(2):156-62. doi: 10.1016/j.canlet.2010.11.001. Epub 2011 Jan 8. Review.

PMID:
21220186
9.

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis.

Holland PM, Miller R, Jones J, Douangpanya H, Piasecki J, Roudier M, Dougall WC.

Cancer Biol Ther. 2010 Apr 1;9(7):539-50. Epub 2010 Apr 1.

PMID:
20150760
10.

RIP4 regulates epidermal differentiation and cutaneous inflammation.

Rountree RB, Willis CR, Dinh H, Blumberg H, Bailey K, Dean C Jr, Peschon JJ, Holland PM.

J Invest Dermatol. 2010 Jan;130(1):102-12. doi: 10.1038/jid.2009.223.

11.

Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells.

Lippa MS, Strockbine LD, Le TT, Branstetter DG, Strathdee CA, Holland PM.

Apoptosis. 2007 Aug;12(8):1465-78.

PMID:
17440816
12.

Protein kinase C-associated kinase is not required for the development of peripheral B lymphocyte populations.

Moran ST, Cariappa A, Liu H, Boboila C, Shi HN, Holland PM, Peschon JJ, Pillai S.

Mol Immunol. 2006 Apr;43(10):1694-9. Epub 2005 Oct 26.

PMID:
16256200
13.

Miniaturized system of a gas chromatograph coupled with a Paul ion trap mass spectrometer.

Shortt BJ, Darrach MR, Holland PM, Chutjian A.

J Mass Spectrom. 2005 Jan;40(1):36-42. Erratum in: J Mass Spectrom. 2005 Apr;40(4)549.

PMID:
15619267
14.

Purification, cloning, and characterization of Nek8, a novel NIMA-related kinase, and its candidate substrate Bicd2.

Holland PM, Milne A, Garka K, Johnson RS, Willis C, Sims JE, Rauch CT, Bird TA, Virca GD.

J Biol Chem. 2002 May 3;277(18):16229-40. Epub 2002 Feb 25.

15.

Protein modification: docking sites for kinases.

Holland PM, Cooper JA.

Curr Biol. 1999 May 6;9(9):R329-31. Review.

16.
17.

MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous.

Holland PM, Suzanne M, Campbell JS, Noselli S, Cooper JA.

J Biol Chem. 1997 Oct 3;272(40):24994-8.

18.

Educational program available on diabetic retinopathy.

Holland PM.

Tex Med. 1993 Nov;89(11):7-8. No abstract available.

PMID:
8284779
19.

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Holland PM, Abramson RD, Watson R, Gelfand DH.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7276-80.

20.

'Very late onset' cystoid macular edema.

Mao LK, Holland PM.

Ophthalmic Surg. 1988 Sep;19(9):633-5.

PMID:
3186172
21.
22.

Evolution of a retinal arterial macroaneurysm.

Holland PM.

Ann Ophthalmol. 1984 Dec;16(12):1167-70.

PMID:
6532292
23.

The Taylor Smith approach to giant tears : in perspective.

Holland PM.

Retina. 1983 Fall-Winter;3(4):293-5. No abstract available.

PMID:
6675104
24.

Broad scleral buckle in the management of retinal detachments with giant tears.

Holland PM, Smith TR.

Am J Ophthalmol. 1977 Apr;83(4):518-25.

PMID:
868954
25.

Levodopa-stimulated growth hormone secretion and diabetic retinopathy.

Holland PM, Landers MB 3rd, Lebovitz HE, Wolbarsht ML.

Am J Ophthalmol. 1976 Oct;82(4):612-8.

PMID:
970425
26.

Myelinated nerve fibers and severe myopia.

Holland PM, Anderson B Jr.

Am J Ophthalmol. 1976 May;81(5):597-9.

PMID:
1275037
28.

Adult color vision screening. Comparison of stereoscopic vision tester slide with Ishihara plates.

Holland PM.

Arch Ophthalmol. 1972 Dec;88(6):613-6. No abstract available.

PMID:
4538939
29.

Modified Landolt rings and Sloan letters in adult visual acuity screening.

Holland PM, Banks WV.

Am J Ophthalmol. 1971 Nov;72(5):983-7. No abstract available.

PMID:
5119712

Supplemental Content

Loading ...
Support Center